Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study

NCT ID: NCT04269902

**Summary of the EVOLVE CLL/SLL Study** The EVOLVE CLL/SLL study is a clinical trial designed to find out if starting treatment for high-risk chronic lymphocytic leukemia (CLL) or small lymphocyti...

Recruiting

Phase: PHASE3 Conditions: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma

Evaluating the Addition of the Immunotherapy Drug Atezolizumab to Standard Chemotherapy Treatment for Advanced or Metastatic Neuroendocrine Carcinomas That Originate Outside the Lung

NCT ID: NCT05058651

This clinical trial is studying the effects of a new immunotherapy drug called atezolizumab when combined with standard chemotherapy for patients with advanced or metastatic neuroendocrine carcinom...

Recruiting

Phase: PHASE2 Conditions: Recurrent Extrapulmonary Neuroendocrine Carcinoma, Unresectable Extrapulmonary Neuroendocrine Carcinoma +2 more

Study to Compare Axicabtagene Ciloleucel With Standard of Care Therapy as First-line Treatment in Participants With High-risk Large B-cell Lymphoma

NCT ID: NCT05605899

This clinical trial is looking at a new treatment called axicabtagene ciloleucel for patients with high-risk large B-cell lymphoma (LBCL), a type of cancer that affects the lymphatic system. The go...

Recruiting

Phase: PHASE3 Conditions: High-risk Large B-cell Lymphoma (LBCL)

A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis

NCT ID: NCT06025578

This clinical trial is studying a new medication called BMS-986278 to see how well it works, how safe it is, and how well patients tolerate it for people with a condition called Progressive Pulmona...

Recruiting

Phase: PHASE3 Conditions: Progressive Pulmonary Fibrosis

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

NCT ID: NCT06283966

This clinical trial is studying a new inhaler that combines three medications—budesonide, glycopyrronium, and formoterol—to see how well it works in improving heart and lung health in people with C...

Recruiting

Phase: PHASE3 Conditions: COPD (Chronic Obstructive Pulmonary Disease)

Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy

NCT ID: NCT06309966

This clinical trial is studying a new treatment called BHV-7000 to see if it can help adults with refractory focal epilepsy, which means their seizures are difficult to control with current medicat...

Recruiting

Phase: PHASE2 Conditions: Focal Epilepsy

A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyoderma Gangrenosum

NCT ID: NCT06624670

This clinical trial is studying a medication called spesolimab to see if it helps people with a skin condition known as pyoderma gangrenosum (PG). Specifically, the trial is looking to find out if ...

Recruiting

Phase: PHASE3 Conditions: Pyoderma Gangrenosum

Assessing the Impact of Perceptions of Unpredictability on Objective Measures of Food Consumption and Metabolism

NCT ID: NCT06690294

This clinical trial is looking at how experiences from childhood can affect how adults eat and manage their weight. Researchers want to understand if certain life events during childhood influence ...

Not yet recruiting

Conditions: Healthy Volunteer, Obestity

A Study to Test Different Doses of BI 1584862 in People With a Distinct Form of Age-related Macular Degeneration (AMD) Called Geographic Atrophy

NCT ID: NCT06769048

This clinical trial is studying a medication called BI 1584862 to see if it can help improve vision in adults aged 55 and older who have a specific type of age-related macular degeneration (AMD) kn...

Recruiting

Phase: PHASE2 Conditions: Geographic Atrophy

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

NCT ID: NCT04267848

The ALCHEMIST trial is a clinical study looking at whether adding a drug called pembrolizumab, which is a type of immunotherapy, to standard chemotherapy can improve treatment outcomes for patients...

Recruiting

Phase: PHASE3 Conditions: Stage IIIB Lung Cancer AJCC v8, Stage IIIA Lung Cancer AJCC v8 +4 more

Comparing the New Anti-cancer Drug Eribulin With Chemotherapy Against the Usual Chemotherapy Alone in Metastatic Urothelial Cancer

NCT ID: NCT04579224

This clinical trial is looking at a new treatment for patients with metastatic urothelial cancer, which is a type of cancer that affects the bladder and other parts of the urinary system. Specifica...

Recruiting

Phase: PHASE3 Conditions: Metastatic Urothelial Carcinoma, Stage IV Bladder Cancer AJCC v8 +3 more

A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies

NCT ID: NCT05006716

This clinical trial is studying a new treatment called BGB-16673 for patients with specific types of B-cell cancers, such as Marginal Zone Lymphoma, Follicular Lymphoma, and Chronic Lymphocytic Leu...

Recruiting

Phase: PHASE1 Conditions: Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma +7 more

Testing the Effects of Novel Therapeutics for Newly Diagnosed, Untreated Patients With High-Risk Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)

NCT ID: NCT05554406

This clinical trial, called the MyeloMATCH Treatment Trial, is investigating different treatment options for adults who have recently been diagnosed with a serious form of blood cancer called high-...

Recruiting

Phase: PHASE2 Conditions: Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm +2 more

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

NCT ID: NCT05564377

The ComboMATCH Screening Trial is a study that aims to find effective treatments for patients with advanced solid tumors, such as certain types of breast cancer and other cancers that have spread e...

Recruiting

Phase: PHASE2 Conditions: Recurrent Ovarian Carcinoma, Metastatic Malignant Solid Neoplasm +13 more

Study of Chemotherapy, With or Without Binimetinib in Advanced Biliary Tract Cancers in 2nd Line Setting (A ComboMATCH Treatment Trial)

NCT ID: NCT05564403

This clinical trial, called the ComboMATCH treatment trial, is studying a new way to treat advanced biliary tract cancers, which include cancers of the bile ducts and gallbladder that have come bac...

Recruiting

Phase: PHASE2 Conditions: Stage III Intrahepatic Cholangiocarcinoma AJCC v8, Stage IV Intrahepatic Cholangiocarcinoma AJCC v8 +15 more

A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

NCT ID: NCT05675410

This clinical trial is studying whether adding two specific drugs, brentuximab vedotin and nivolumab, to the standard treatment for early-stage Hodgkin lymphoma can help patients live longer and ex...

Recruiting

Phase: PHASE3 Conditions: Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8

A Study to Compare Darolutamide Given With Androgen Deprivation Therapy (ADT) With ADT in Men With Hormone Sensitive Prostate Cancer and Raise of Prostate Specific Antigen (PSA) Levels After Local Therapies

NCT ID: NCT05794906

This clinical trial is studying a new treatment approach for men who have hormone-sensitive prostate cancer that has returned after initial treatment, indicated by rising levels of a protein called...

Recruiting

Phase: PHASE3 Conditions: Biochemically Recurrent Prostate Cancer

Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM

NCT ID: NCT05902169

This clinical trial, called Sonocloud-9, is exploring a new treatment method for patients with recurrent glioblastoma, a type of brain cancer. The goal is to see if combining a chemotherapy drug ca...

Recruiting

Phase: PHASE3 Conditions: Glioblastoma, Recurrent Glioblastoma +1 more

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

NCT ID: NCT06172296

This clinical trial is studying a new treatment approach for children with high-risk neuroblastoma, a type of cancer that affects nerve cells. The researchers want to find out if combining a medici...

Recruiting

Phase: PHASE3 Conditions: Neuroblastoma, Ganglioneuroblastoma, Nodular

A Study to Determine if BHV-7000 is Effective and Safe in Adults With Idiopathic Generalized Epilepsy With Generalized Tonic-clonic Seizures

NCT ID: NCT06425159

This clinical trial is studying a new treatment called BHV-7000 to see if it is effective and safe for adults with idiopathic generalized epilepsy, specifically those who experience generalized ton...

Recruiting

Phase: PHASE2 Conditions: Generalized Epilepsy

Main Menu

Clinical Trials in Phoenix, Arizona

976 Active Trials Found in Phoenix

Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study

Evaluating the Addition of the Immunotherapy Drug Atezolizumab to Standard Chemotherapy Treatment for Advanced or Metastatic Neuroendocrine Carcinomas That Originate Outside the Lung

Study to Compare Axicabtagene Ciloleucel With Standard of Care Therapy as First-line Treatment in Participants With High-risk Large B-cell Lymphoma

A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy

A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyoderma Gangrenosum

Assessing the Impact of Perceptions of Unpredictability on Objective Measures of Food Consumption and Metabolism

A Study to Test Different Doses of BI 1584862 in People With a Distinct Form of Age-related Macular Degeneration (AMD) Called Geographic Atrophy

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Comparing the New Anti-cancer Drug Eribulin With Chemotherapy Against the Usual Chemotherapy Alone in Metastatic Urothelial Cancer

A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies

Testing the Effects of Novel Therapeutics for Newly Diagnosed, Untreated Patients With High-Risk Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

Study of Chemotherapy, With or Without Binimetinib in Advanced Biliary Tract Cancers in 2nd Line Setting (A ComboMATCH Treatment Trial)

A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

A Study to Compare Darolutamide Given With Androgen Deprivation Therapy (ADT) With ADT in Men With Hormone Sensitive Prostate Cancer and Raise of Prostate Specific Antigen (PSA) Levels After Local Therapies

Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

A Study to Determine if BHV-7000 is Effective and Safe in Adults With Idiopathic Generalized Epilepsy With Generalized Tonic-clonic Seizures